591 related articles for article (PubMed ID: 28356053)
1. Levetiracetam in Compare to Sodium Valproate for Prophylaxis in Chronic Migraine Headache: A Randomized Double-Blind Clinical Trial.
Kashipazha D; Ghadikolaei HS; Siavashi M
Curr Clin Pharmacol; 2017; 12(1):55-59. PubMed ID: 28356053
[TBL] [Abstract][Full Text] [Related]
2. Use of melatonin versus valproic acid in prophylaxis of migraine patients: A double-blind randomized clinical trial.
Ebrahimi-Monfared M; Sharafkhah M; Abdolrazaghnejad A; Mohammadbeigi A; Faraji F
Restor Neurol Neurosci; 2017; 35(4):385-393. PubMed ID: 28800342
[TBL] [Abstract][Full Text] [Related]
3. Effect of intravenous sodium valproate vs dexamethasone on acute migraine headache: a double blind randomized clinical trial.
Mazaheri S; Poorolajal J; Hosseinzadeh A; Fazlian MM
PLoS One; 2015; 10(3):e0120229. PubMed ID: 25793707
[TBL] [Abstract][Full Text] [Related]
4. The effects of cinnarizine versus sodium valproate in migraine prophylaxis.
Bostani A; Rajabi A; Moradian N; Razazian N; Rezaei M
Int J Neurosci; 2013 Jul; 123(7):487-93. PubMed ID: 23311688
[TBL] [Abstract][Full Text] [Related]
5. Sodium valproate in migraine without aura and medication overuse headache: a randomized controlled trial.
Sarchielli P; Messina P; Cupini LM; Tedeschi G; Di Piero V; Livrea P; Pini LA; Bernardi G; Bono G; Sandrini G; Caproni S; Corbelli I; Pisani F; Beghi E; Calabresi P;
Eur Neuropsychopharmacol; 2014 Aug; 24(8):1289-97. PubMed ID: 24862255
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of the effects of low-dose topiramate versus sodium valproate in migraine prophylaxis.
Afshari D; Rafizadeh S; Rezaei M
Int J Neurosci; 2012 Feb; 122(2):60-8. PubMed ID: 21950578
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial.
Khani S; Hejazi SA; Yaghoubi M; Sharifipour E
J Headache Pain; 2021 Apr; 22(1):21. PubMed ID: 33827421
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
9. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
10. Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: A randomized, prospective, parallel, open-label study.
Dakhale GN; Sharma VS; Thakre MN; Kalikar M
Indian J Pharmacol; 2019; 51(4):255-262. PubMed ID: 31571712
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous histamine versus sodium valproate in migraine prophylaxis: a randomized, controlled, double-blind study.
Millán-Guerrero RO; Isais-Millán R; Barreto-Vizcaíno S; Rivera-Castaño L; Garcia-Solorzano A; López-Blanca C; Membrila-Maldonado M; Muñoz-Solis R
Eur J Neurol; 2007 Oct; 14(10):1079-84. PubMed ID: 17880560
[TBL] [Abstract][Full Text] [Related]
12. Intravenous valproate sodium in the treatment of daily headache.
Schwartz TH; Karpitskiy VV; Sohn RS
Headache; 2002 Jun; 42(6):519-22. PubMed ID: 12167141
[TBL] [Abstract][Full Text] [Related]
13. Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial.
Mitsikostas DD; Polychronidis I
Funct Neurol; 1997; 12(5):267-76. PubMed ID: 9439944
[TBL] [Abstract][Full Text] [Related]
14. Comparing the Effects of Atorvastatin With Sodium Valproate (Divalproex) on Frequency and Intensity of Frequent Migraine Headaches: A Double-blind Randomized Controlled Study.
Hesami O; Sistanizad M; Asadollahzade E; Johari MS; Beladi-Moghadam N; Mazhabdar-Ghashghai H
Clin Neuropharmacol; 2018; 41(3):94-97. PubMed ID: 29746282
[TBL] [Abstract][Full Text] [Related]
15. Cinnarizine and sodium valproate as the preventive agents of pediatric migraine: A randomized double-blind placebo-controlled trial.
Amanat M; Togha M; Agah E; Ramezani M; Tavasoli AR; Azizi Malamiri R; Fashandaky F; Heidari M; Salehi M; Eshaghi H; Ashrafi MR
Cephalalgia; 2020 Jun; 40(7):665-674. PubMed ID: 31707814
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of magnesium oxide and sodium valproate in prevention of migraine headache: a randomized, controlled, double-blind, crossover study.
Karimi N; Razian A; Heidari M
Acta Neurol Belg; 2021 Feb; 121(1):167-173. PubMed ID: 30798472
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients.
Bidabadi E; Mashouf M
Paediatr Drugs; 2010 Aug; 12(4):269-75. PubMed ID: 20593910
[TBL] [Abstract][Full Text] [Related]
18. Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial.
Tanen DA; Miller S; French T; Riffenburgh RH
Ann Emerg Med; 2003 Jun; 41(6):847-53. PubMed ID: 12764341
[TBL] [Abstract][Full Text] [Related]
19. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap.
Cady R; Nett R; Dexter K; Freitag F; Beach ME; Manley HR
Headache; 2014 Jan; 54(1):80-93. PubMed ID: 24020994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
